000 | 01829 a2200601 4500 | ||
---|---|---|---|
005 | 20250514044356.0 | ||
264 | 0 | _c19930203 | |
008 | 199302s 0 0 eng d | ||
022 | _a1012-8689 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEl Sahwi, S | |
245 | 0 | 0 |
_aHysteroscopic and hysterosalpingographic study after intrauterine insertion of quinacrine pellets for non-surgical sterilization. _h[electronic resource] |
260 |
_bAdvances in contraceptive delivery systems : CDS _c1992 |
||
300 |
_a151-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAfrica |
650 | 0 | 4 | _aAfrica, Northern |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aBiology |
650 | 0 | 4 | _aBirth Rate |
650 | 0 | 4 | _aContraception |
650 | 0 | 4 | _aContraception Behavior |
650 | 0 | 4 | _aDemography |
650 | 0 | 4 | _aDeveloping Countries |
650 | 0 | 4 | _aDiagnosis |
650 | 0 | 4 | _aEgypt |
650 | 0 | 4 | _aEndometrium |
650 | 0 | 4 | _aFamily Planning Services |
650 | 0 | 4 | _aFertility |
650 | 0 | 4 | _aGenitalia |
650 | 0 | 4 | _aGenitalia, Female |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHysterosalpingography |
650 | 0 | 4 | _aMiddle East |
650 | 0 | 4 | _aParity |
650 | 0 | 4 | _aPatient Acceptance of Health Care |
650 | 0 | 4 | _aPharmaceutical Preparations |
650 | 0 | 4 | _aPhysical Examination |
650 | 0 | 4 | _aPhysiology |
650 | 0 | 4 | _aPopulation |
650 | 0 | 4 | _aPopulation Characteristics |
650 | 0 | 4 | _aPopulation Dynamics |
650 | 0 | 4 | _aQuinacrine |
650 | 0 | 4 | _aSterilization, Reproductive |
650 | 0 | 4 | _aSterilization, Tubal |
650 | 0 | 4 | _aTherapeutics |
650 | 0 | 4 | _aUrogenital System |
650 | 0 | 4 | _aUterus |
700 | 1 | _aKamel, M | |
700 | 1 | _aHaiba, N | |
700 | 1 | _aOsman, M | |
773 | 0 |
_tAdvances in contraceptive delivery systems : CDS _gvol. 8 _gno. 1-2 _gp. 151-9 |
|
999 |
_c12135692 _d12135692 |